Aberrant cytoplasmic localization of N-CoR in colorectal tumors

Vanessa Fernández-Majada1, Jaume Pujadas, Felip Vilardell

  • 1Centre Oncologia Molecular, Institut d'Investigacio Biomèdica de Bellvitge, Hospitalet, Barcelona, Spain.

Insights

Inhibitor of kappaB kinases (IKKs) activate in colon cancer, causing Nuclear Receptor corepressor (N-CoR) to shift to the cytoplasm. This aberrant N-CoR localization is a common feature in colorectal tumors.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Aberrant activation of Inhibitor of kappaB kinases (IKKs) is observed in colon cancer cells.
  • This activation leads to SMRT phosphorylation and subsequent release from chromatin.

Purpose of the Study:

  • To investigate the phosphorylation of Nuclear Receptor corepressor (N-CoR) by IKKalpha.
  • To analyze the subcellular localization of N-CoR in colorectal cancer samples.

Main Methods:

  • Biochemical assays to determine IKKalpha-mediated phosphorylation sites on N-CoR.
  • Analysis of N-CoR subcellular distribution in 43 human colorectal cancer tissues.

Main Results:

  • IKKalpha phosphorylates N-CoR at serines 2345 and 2348, creating a 14-3-3 binding domain.
  • Aberrant cytoplasmic localization of N-CoR was identified as a general characteristic in colorectal tumors.

Conclusions:

  • IKKalpha-mediated phosphorylation of N-CoR contributes to its altered subcellular distribution in colon cancer.
  • The cytoplasmic mislocalization of N-CoR is a prevalent feature in colorectal cancer, suggesting a role in tumorigenesis.

Related Concept Videos